Anti-beta 2-glycoprotein I, antiprothrombin antibodies, and the risk of thrombosis in the antiphospholipid syndrome.

The association of antiphospholipid antibodies with thrombosis and obstetric events defines the antiphospholipid syndrome. A recent systematic review of the literature showed lupus anticoagulants to be risk factors of thrombosis, independent of the type and site of the event, the presence of

[1]  M. Bijl,et al.  The antiphospholipid syndrome II , 2004 .

[2]  T. Barbui,et al.  Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature. , 2003, Blood.

[3]  L. Horstman,et al.  Factor VII/VIIa: a new antigen in the anti‐phospholipid antibody syndrome , 2003, British journal of haematology.

[4]  T. Barbui,et al.  Anti-β2-Glycoprotein I and Anti-Prothrombin Antibodies in Antiphospholipid-Negative Patients with Thrombosis , 2002, Thrombosis and Haemostasis.

[5]  T. Kveder,et al.  Inter-laboratory variability of anti-beta2-glycoprotein I measurement. A collaborative study in the frame of the European Forum on Antiphospholipid Antibodies Standardization Group. , 2002, Thrombosis and haemostasis.

[6]  R. Derksen,et al.  β2-glycoprotein-I and Anti-β2-glycoprotein-I Antibodies1 , 2002 .

[7]  S. Pierangeli,et al.  Antibodies to Cardiolipin and other Phospholipids , 2002 .

[8]  M. Boffa,et al.  Lupus Anticoagulants: Detection, Standardization, and Heterogeneity , 2002 .

[9]  R. Asherson.  The antiphospholipid syndrome II : autoimmune thrombosis , 2002 .

[10]  Y. Kanakura,et al.  Anti‐prothrombin antibodies combined with lupus anti‐coagulant activity is an essential risk factor for venous thromboembolism in patients with systemic lupus erythematosus , 2001, British journal of haematology.

[11]  J. Amiral,et al.  A Cross Sectional Study of Antiphospholipid-protein Antibodies in Patients with Venous Thromboembolism , 2001, Thrombosis and Haemostasis.

[12]  S. Kittner,et al.  &bgr;2-Glycoprotein 1–Dependent Anticardiolipin Antibodies and Risk of Ischemic Stroke and Myocardial Infarction: The Honolulu Heart Program , 2001, Stroke.

[13]  J. Arnout,et al.  Antiphospholipid Syndrome: Diagnostic Aspects of Lupus Anticoagulants , 2001, Thrombosis and Haemostasis.

[14]  A. Ko,et al.  Anti-beta2 glycoprotein I and anticardiolipin antibodies in leptospirosis, syphilis and Kala-azar. , 2001, Clinical and experimental rheumatology.

[15]  D. Isenberg,et al.  Anti‐prothrombin antibodies: assay conditions and clinical associations in the anti‐phospholipid syndrome , 2001, British journal of haematology.

[16]  S. S. Lee,et al.  Isotypes of anti-beta2-glycoprotein I antibodies: association with thrombosis in patients with systemic lupus erythematosus. , 2001, The Journal of rheumatology.

[17]  A. Rosato,et al.  Some Patients with Antiphospholipid Syndrome Express hitherto Undescribed Antibodies to Cardiolipin-binding Proteins , 2001, Thrombosis and Haemostasis.

[18]  T. Barbui,et al.  Lupus Anticoagulants and Thrombosis: Clinical Association of Different Coagulation and Immunologic Tests , 2000, Thrombosis and Haemostasis.

[19]  I. Bruce,et al.  Prevalence of antibodies to beta2-glycoprotein I in systemic lupus erythematosus and their association with antiphospholipid antibody syndrome criteria: a single center study and literature review. , 2000, The Journal of rheumatology.

[20]  A. Tsutsumi,et al.  Association of autoantibodies against the phosphatidylserine-prothrombin complex with manifestations of the antiphospholipid syndrome and with the presence of lupus anticoagulant. , 2000, Arthritis and rheumatism.

[21]  I. Olkin,et al.  Meta-analysis of observational studies in epidemiology - A proposal for reporting , 2000 .

[22]  M. Zeher,et al.  Antiprothrombin and antiannexin V antibodies imply risk of thrombosis in patients with systemic autoimmune diseases. , 2000, The Journal of rheumatology.

[23]  E. Angles-cano,et al.  Antibodies to tissue‐type plasminogen activator in plasma from patients with primary antiphospholipid syndrome , 2000, British journal of haematology.

[24]  R. Priori,et al.  Is there a Role for Anti-phospholipid-binding Protein Antibodies in the Pathogenesis of Thrombosis in Behcet’s Disease? , 2000, Thrombosis and Haemostasis.

[25]  G. Espinosa,et al.  Prevalence and clinical significance of antiprothrombin antibodies in patients with systemic lupus erythematosus or with primary antiphospholipid syndrome. , 2000, Haematologica.

[26]  Paolo Prandoni,et al.  Anti-β2-Glycoprotein I Antibodies in Patients with Acute Venous Thromboembolism , 1999 .

[27]  M. Egger,et al.  The hazards of scoring the quality of clinical trials for meta-analysis. , 1999, JAMA.

[28]  W A Wilson,et al.  International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. , 1999, Arthritis and rheumatism.

[29]  T. Barbui,et al.  Antiprothrombin antibodies: detection and clinical significance in the antiphospholipid syndrome. , 1999, Blood.

[30]  D. W. Jones,et al.  Antibodies to Factor XII Associated with Lupus Anticoagulant , 1999, Thrombosis and Haemostasis.

[31]  P. Prandoni,et al.  Anti-beta2-glycoprotein I antibodies in patients with acute venous thromboembolism: prevalence and association with recurrent thromboembolism. , 1999, Thrombosis research.

[32]  G. Valesini,et al.  Anti-prothrombin but not “pure” Anti-cardiolipin Antibodies Are Associated with the Clinical Features of the Antiphospholipid Antibody Syndrome , 1998, Thrombosis and Haemostasis.

[33]  P. Giordano,et al.  Lupus anticoagulant, anticardiolipin antibodies and hepatitis C virus infection in thalassaemia , 1998, British journal of haematology.

[34]  L. Carreras,et al.  Lupus anticoagulant, high levels of anticardiolipin, and anti-beta2-glycoprotein I antibodies are associated with chronic thromboembolic pulmonary hypertension. , 1998, The Journal of rheumatology.

[35]  G. Hughes,et al.  Autoantibodies to human prothrombin and clinical manifestations in 207 patients with systemic lupus erythematosus. , 1998, The Journal of rheumatology.

[36]  J. Reveille,et al.  Autoantibodies to beta2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: clinical correlations in comparison with other antiphospholipid antibody tests. , 1998, The Journal of rheumatology.

[37]  M. Teodorescu,et al.  High frequency of abnormal levels of IgA anti-beta2-glycoprotein I antibodies in patients with systemic lupus erythematosus: relationship with antiphospholipid syndrome. , 1998, The Journal of rheumatology.

[38]  J. Virtamo,et al.  High Antibody Levels to Prothrombin Imply a Risk of Deep Venous Thrombosis and Pulmonary Embolism in Middle-aged Men , 1997, Thrombosis and Haemostasis.

[39]  L. Carreras,et al.  Relationship of Anti β2-giycoprotein I and Anti Prothrombin Antibodies to Thrombosis and Pregnancy Loss in Patients with Antiphospholipid Antibodies , 1997, Thrombosis and Haemostasis.

[40]  A. Szczeklik,et al.  Anticardiolipin, anti-beta(2)-glycoprotein I, antiprothrombin antibodies, and lupus anticoagulant in patients with systemic lupus erythematosus with a history of thrombosis. , 1997, The Journal of rheumatology.

[41]  C. Feighery,et al.  Antibodies to β2‐glycoprotein I—a specific marker for the antiphospholipid syndrome , 1997, Clinical and experimental immunology.

[42]  D. Raoult,et al.  Prevalence and clinical significance of IgG isotype anti-β2-glycoprotein I antibodies in antiphospholipid syndrome: A comparative study w , 1997 .

[43]  T. Barbui,et al.  Different Anticoagulant and Immunological Properties of Anti-Prothrombin Antibodies in Patients with Antiphospholipid Antibodies , 1997, Thrombosis and Haemostasis.

[44]  D. Raoult,et al.  Prevalence and clinical significance of IgG isotype anti-beta 2-glycoprotein I antibodies in antiphospholipid syndrome: a comparative study with anticardiolipin antibodies. , 1997, The Journal of laboratory and clinical medicine.

[45]  G. Hughes,et al.  Specificity of ELISA for antibody to beta 2-glycoprotein I in patients with antiphospholipid syndrome. , 1996, British journal of rheumatology.

[46]  P. D. de Groot,et al.  Lupus Anticoagulant is the Strongest Risk Factor for both Venous and Arterial Thrombosis in Patients with Systemic Lupus Erythematosus , 1996, Thrombosis and Haemostasis.

[47]  A. Tsutsumi,et al.  Antibodies to β2-glycoprotein I and clinical manifestations in patients with systemic lupus erythematosus , 1996 .

[48]  M. Maldonado,et al.  Comparison of an enzyme-linked immunosorbent assay for antibodies to beta 2-glycoprotein I and a conventional anticardiolipin immunoassay. , 1996, Arthritis and rheumatism.

[49]  O. Vaarala,et al.  Antibodies to phospholipid-binding plasma proteins and occurrence of thrombosis in patients with systemic lupus erythematosus. , 1996, Clinical immunology and immunopathology.

[50]  A. Biasiolo,et al.  Autoantibodies to Phospholipid-binding Plasma Proteins in Patients with Thrombosis and Phospholipid-reactive Antibodies , 1996, Thrombosis and Haemostasis.

[51]  O. Vaarala,et al.  Antibodies to Prothrombin Imply a Risk of Myocardial Infarction in Middle-Aged Men , 1996, Thrombosis and Haemostasis.

[52]  T. Sugi,et al.  Autoantibodies to phosphatidylethanolamine (PE) recognize a kininogen- PE complex , 1995 .

[53]  D. Alarcón-Segovia,et al.  Antibodies to phospholipid-free beta 2-glycoprotein-I in patients with primary antiphospholipid syndrome. , 1995, The Journal of rheumatology.

[54]  I. Scharrer,et al.  Criteria for the Diagnosis of Lupus Anticoagulants: An Update , 1995, Thrombosis and Haemostasis.

[55]  G. Reber,et al.  Development of an ELISA for Autoantibodies to Prothrombin Showing their Prevalence in Patients with Lupus Anticoagulants , 1995, Thrombosis and Haemostasis.

[56]  D. Alarcón-Segovia,et al.  Clinical manifestations of the antiphospholipid syndrome in patients with systemic lupus erythematosus associate more strongly with anti-beta 2-glycoprotein-I than with antiphospholipid antibodies. , 1995, The Journal of rheumatology.

[57]  G A Colditz,et al.  Heterogeneity in meta-analysis of data from epidemiologic studies: a commentary. , 1995, American journal of epidemiology.

[58]  A. Tincani,et al.  Anti-beta 2-glycoprotein I antibodies: a marker of antiphospholipid syndrome? , 1995, Lupus.

[59]  L. Carreras,et al.  Anti β2 glycoprotein I antibodies: detection and association with thrombosis , 1995 .

[60]  J. Matsuda,et al.  Anti‐annexin V antibody in systemic lupus erythematosus patients with lupus anticoagulant and/or anticardiolipin antibody , 1994, American journal of hematology.

[61]  M. Jauhiainen,et al.  Crossreaction between antibodies to oxidised low-density lipoprotein and to cardiolipin in systemic lupus erythematosus , 1993, The Lancet.

[62]  P. D. de Groot,et al.  Antiphospholipid antibodies directed against a combination of phospholipids with prothrombin, protein C, or protein S: an explanation for their pathogenic mechanism? , 1993, Blood.

[63]  Z. Amoura,et al.  Association of anti-β2 glycoprotein I antibodies with lupus-type circulating anticoagulant and thrombosis in systemic lupus erythematosus☆ , 1992 .

[64]  D. Felson,et al.  Bias in meta-analytic research. , 1992, Journal of clinical epidemiology.

[65]  T. Barbui,et al.  Lupus Anticoagulant IgG's (LA) Are Not Directed to Phospholipids only, but to a Complex of Lipid-Bound Human Prothrombin , 1991, Thrombosis and Haemostasis.

[66]  T. Koike,et al.  Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease , 1990, The Lancet.

[67]  T. Barbui,et al.  Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor , 1990, The Lancet.

[68]  C. Chesterman,et al.  Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H). , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[69]  G. Hughes,et al.  The “Primary” Antiphospholipid Syndrome: Major Clinical and Serological Features , 1989, Medicine.

[70]  J. Sánchez-Guerrero,et al.  Antiphospholipid Antibodies and the Antiphospholipid Syndrome in Systemic Lupus Erythematosus A Prospective Analysis of 500 Consecutive Patients , 1989, Medicine.

[71]  O. Vaarala,et al.  Anticardiolipin response in acute infections. , 1986, Clinical immunology and immunopathology.